Related Experiment Video
Updated: Aug 19, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Education, motivation and medication for African Americans: bringing hypertension guidelines to practice
David Martins1, Naureen Tareen, Susanne B Nicholas
1Charles R. Drew University of Medicine & Science, Los Angeles, CA 90059, USA.
Insights
African Americans experience high hypertension rates. While drug responses may vary, major trials show no significant racial differences in key outcomes with standard care, emphasizing system and socio-economic factors for better blood pressure management.
Area of Science:
- Cardiology
- Public Health
- Health Disparities
Background:
- African Americans exhibit disproportionately high rates of hypertension and related complications.
- Existing research indicates potential racial/ethnic variations in blood pressure responses to specific pharmacologic therapies.
Purpose of the Study:
- To evaluate whether class-specific racial/ethnic differences exist in key clinical outcomes for hypertension among African Americans.
- To identify factors beyond pharmacologic therapy that influence hypertension management in this population.
Main Methods:
- Analysis of data from randomized hypertension trials with substantial African American enrollment.
- Assessment of clinical outcomes under standardized medical care protocols.
Main Results:
- Most trials did not support class-specific racial/ethnic differences in key clinical outcomes.
- The study highlights the importance of healthcare systems, socio-economic, and demographic factors.
Conclusions:
- Pharmacologic therapy outcomes in hypertension do not appear to differ significantly by race in major trials with standardized care.
- Optimizing blood pressure control and end-organ protection requires addressing healthcare system barriers and socio-economic determinants impacting patient engagement and access.
Abstract:
African Americans suffer from high rates of hypertension and hypertension-related complications. While racial/ethnic differences in blood pressure response to pharmacologic therapy have been described, most randomized hypertension trials with substantial enrollment of African Americans receiving standardized medical care do not support class-specific racial/ethnic differences in key clinical outcomes. Understanding health care systems and the socio-economic and demographic factors that impair access can enhance the ability of the provider to enlist and engage the patient for optimal blood pressure control and end organ protection.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Atherosclerosis III: Management
Factors affecting Blood pressure
Physiological Factors:
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies